surpass-cvot tirzepatide shows delivers comparable cardiovascular safety to dulaglutide in patients with type 2 diabetes and established ASCVD, reinforcing the shift toward therapies that optimize whole cardiometabolic systems. As outcome datasets grow AHA 25: SURPASS-CVOT:Tirzepatide vs Dulaglutide

Obesity is known to increase the risk of at least 13 different types of cancer so reducing body weight would almost certainly reduce ones risk for those particular cancers, he said.

Norway: Similar to Sweden, with Regional Variations In Norway: Wegovy and Saxenda are both approved Public healthcare only covers the cost of these medicines for diabetes treatment

Furthermore, no convincing evidence currently supports a direct association between gut microbiota composition and the risk of GLP-1 receptor agonist-associated pancreatitis

It's a medical solution that helps you lose weight and improve your overall well-being

27-28 But berberine also exerts many other mechanisms that help in weight management

Taking it right at bedtime, or worse, in the morning and expecting sleep benefits that same night, is not how the mechanism works